INCYTE CORP logo

INCYTE CORP (INCY)

Services-Commercial Physical & Biological Research ยท Technology ยท $19.9B

undervalued
Intrinsic Value (Consensus)
$142.89
Current Price
$99.75
Margin of Safety
+43.2%
43.2% Below Intrinsic Value
Value: $143
Price: $100

Valuation Model Estimates

Current Price: $99.75
DCF (Discounted Cash Flow)
$320.09
Graham Number
$61.05
Earnings Power Value
$62.23
Relative Value (P/E)
$128.20
Dividend Discount Model
Not applicable
โ€”
Consensus Value
$142.89

Model Assumptions

Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%

Discount rate derived from CAPM (risk-free rate + beta ร— market risk premium). Growth rate based on trailing earnings growth, capped at 20%.

Health Score

B
78
Profitability
22/25
Strength
12/25
Valuation
22/25
Growth
22/25

Financial Health Signals

Very high debt โ€” Debt/Equity ratio is 370% (above 200% is risky)
Strong profitability โ€” ROE of 25% (above 20% is excellent)
Strong earnings growth (20% YoY)

Key Financials

EPS (TTM)
$6.41
EPS (Forward)
$7.69
Book Value
$25.84
P/E Ratio
20.0
Forward P/E
16.7
PEG Ratio
โ€”
ROE
24.9%
Debt/Equity
370%
Revenue Growth
21.2%
Earnings Growth
20.0%
Dividend Yield
N/A
Beta
1.00

Data last updated: 2026-06-16

Source: Yahoo Finance